Inhaled corticosteroids are commonly made use of for treating asthma and COPD (chronic obstructive pulmonary disease). These medications may however be related to the development and progression of diabetes.
Researchers have discovered that inhaled corticosteroids were linked to a 34 percent increase in the rate of onset and progression of diabetes. On the highest doses inhaled, the risk increased by 64 percent in onset of diabetes, and 54 percent in the progression of diabetes.
Even though inhaled corticosteroids are advised only for individuals with the most severe COPD, recent practice has resulted in them being used in less severe cases. The fact is, more than 70 percent of all individuals having COPD are making use of inhaled corticosteroids.
Considering that COPD and diabetes have a tendency to increase with age, it’s especially important to determine any possible interaction between the use of inhaled corticosteroids and glycemic control deterioration.
Although the use of intravenous high-dose vitamin C as a treatment for cancer has not been approved the FDA, there have been several successful scientifically documented cases.1
The majority of vitamin C therapies involve administering it orally, Scientists have however proven that administering vitamin C intravenously, which bypasses normal gut metabolism, results in blood levels which are 100 to 500 times more than oral ingestion levels.
Although high doses of vitamin C administered orally can be effective against cancer cells, it’s the super-high blood level concentration of intravenously administered vitamin C that really demonstrates its cancer cell fighting abilities.
Vitamin C and cancer case study 1
A 51-year-old female patient with metastatic cancer refused conventional cancer treatment, choosing instead intravenously administered high-dose vitamin C at a dosage of 65 g twice a week continuing for 10 months